Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · IEX Real-Time Price · USD
6.05
+0.20 (3.42%)
At close: Dec 29, 2023, 4:00 PM
6.00
-0.05 (-0.83%)
After-hours: Dec 29, 2023, 4:15 PM EST
Addex Therapeutics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for ADXN stock.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for ADXN.
Recommendation Trends
| Rating | Feb '22 | Mar '22 | Apr '22 | May '22 | Jun '22 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 23, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $420 → $300 | Strong Buy | Maintains | $420 → $300 | +4,858.68% | May 31, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $560 → $420 | Strong Buy | Maintains | $560 → $420 | +6,842.15% | Feb 11, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $560 | Strong Buy | Initiates | $560 | +9,156.20% | Apr 21, 2021 |
Financial Forecast
Revenue This Year
3.68M
from 1.44M
Increased by 154.75%
Revenue Next Year
3.12M
from 3.68M
Decreased by -15.21%
EPS This Year
-0.14
from -0.46
EPS Next Year
-0.10
from -0.14
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 7.7M | 6.6M | 21.0M | n/a | 7.1M | 4.3M |
| Avg | 3.7M | 3.1M | 11.0M | n/a | 6.9M | 4.1M |
| Low | 1.1M | n/a | 1.5M | n/a | 6.6M | 4.0M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 430.5% | 79.7% | 572.9% | - | - | -38.2% |
| Avg | 154.7% | -15.2% | 251.3% | - | - | -40.0% |
| Low | -25.4% | - | -52.9% | - | - | -42.4% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | -0.11 | -0.09 | 0.22 | -0.10 | - |
| Avg | -0.14 | -0.10 | 0.06 | -0.10 | - |
| Low | -0.17 | -0.10 | -0.10 | -0.09 | - |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.